Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
36,949
Value
$23.0M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202636,949$23.0M<0.1%−3,203−8.0%ReducedHolders
Q1 202640,152$31.0M<0.1%+10,018+33.2%AddedHolders
Q4 202530,134$23.3M<0.1%+10,195+51.1%AddedHolders
Q3 202519,939$11.2M<0.1%+10,454+110.2%AddedHolders
Q2 20259,485$4.98M<0.1%−1,882−16.6%ReducedHolders
Q1 202511,367$7.21M<0.1%+1,209+11.9%AddedHolders
Q4 202410,158$7.24M<0.1%−1,635−13.9%ReducedHolders
Q3 202411,793$12.4M<0.1%+2,178+22.7%AddedHolders
Q2 20249,615$10.1M<0.1%+991+11.5%AddedHolders
Q1 20248,624$8.30M<0.1%+1,535+21.7%AddedHolders
Q4 20237,089$6.23M<0.1%+421+6.3%AddedHolders
Q3 20236,668$5.49M<0.1%+551+9.0%AddedHolders
Q2 20236,117$4.40M<0.1%+350+6.1%AddedHolders
Q1 20235,767$4.74M<0.1%+645+12.6%AddedHolders
Q4 20225,122$3.70M<0.1%+731+16.6%AddedHolders
Q3 20224,391$3.02M<0.1%+467+11.9%AddedHolders
Q2 20223,924$2.32M<0.1%+1,225+45.4%AddedHolders
Q1 20222,699$1.89M<0.1%−25−0.9%ReducedHolders
Q4 20212,724$1.72M<0.1%+270+11.0%AddedHolders
Q3 20212,454$1.49M<0.1%−535−17.9%ReducedHolders
Q2 20212,989$1.67M<0.1%−3,317−52.6%ReducedHolders
Q1 20216,306$2.98M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.